Oluyemi  Okupe net worth and biography

Oluyemi Okupe Biography and Net Worth

Yemi Okupe is our Chief Financial Officer. He brings to Hims & Hers a wealth of experience in financial leadership positions at high-growth, B2C companies that have successfully transformed entire industries. From 2019 to 2021, Yemi served as a Divisional CFO at Uber, first in charge of UberEats – one of the largest food delivery platforms in the world – and later of Uber’s global mobility unit, which included ridesharing, transit, and micro mobility services across 60 countries. Yemi has also served in a number of financial leadership positions at eBay and PayPal – including as Divisional CFO of Braintree – and Google, where he was the finance lead for Google Payments and Google Express. He is a graduate of Stanford Business School.

What is Oluyemi Okupe's net worth?

The estimated net worth of Oluyemi Okupe is at least $2.87 million as of November 25th, 2024. Mr. Okupe owns 109,392 shares of Hims & Hers Health stock worth more than $2,866,070 as of December 21st. This net worth estimate does not reflect any other investments that Mr. Okupe may own. Learn More about Oluyemi Okupe's net worth.

How do I contact Oluyemi Okupe?

The corporate mailing address for Mr. Okupe and other Hims & Hers Health executives is 2269 CHESTNUT STREET SUITE 523, SAN FRANCISCO CA, 94123. Hims & Hers Health can also be reached via phone at 415-851-0195 and via email at [email protected]. Learn More on Oluyemi Okupe's contact information.

Has Oluyemi Okupe been buying or selling shares of Hims & Hers Health?

During the past quarter, Oluyemi Okupe has sold $12,972,975.01 in Hims & Hers Health stock. Most recently, Oluyemi Okupe sold 101,993 shares of the business's stock in a transaction on Monday, November 25th. The shares were sold at an average price of $29.62, for a transaction totalling $3,021,032.66. Following the completion of the sale, the chief financial officer now directly owns 109,392 shares of the company's stock, valued at $3,240,191.04. Learn More on Oluyemi Okupe's trading history.

Who are Hims & Hers Health's active insiders?

Hims & Hers Health's insider roster includes Jack Abraham (Major Shareholder), Melissa Baird (COO), Soleil Boughton (Insider), Patrick Carroll (Insider), Michael Chi (Chief Commercial Officer), Andrew Dudum (Co-Founder, Chairman & CEO), Spencer Lee (CFO), Oluyemi Okupe (CFO), Christopher Payne (Director), and David Wells (Director). Learn More on Hims & Hers Health's active insiders.

Are insiders buying or selling shares of Hims & Hers Health?

In the last year, Hims & Hers Health insiders bought shares 3 times. They purchased a total of 115,000 shares worth more than $2,084,023.00. In the last year, insiders at the sold shares 81 times. They sold a total of 3,280,739 shares worth more than $61,992,612.71. The most recent insider tranaction occured on December, 16th when insider Irene Becklund sold 472 shares worth more than $13,961.76. Insiders at Hims & Hers Health own 17.7% of the company. Learn More about insider trades at Hims & Hers Health.

Information on this page was last updated on 12/16/2024.

Oluyemi Okupe Insider Trading History at Hims & Hers Health

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/25/2024Sell101,993$29.62$3,021,032.66109,392View SEC Filing Icon  
11/13/2024Sell142,886$29.93$4,276,577.98112,186View SEC Filing Icon  
10/14/2024Sell269,739$20.31$5,478,399.09145,763View SEC Filing Icon  
10/7/2024Sell9,868$19.96$196,965.28195,988View SEC Filing Icon  
9/20/2024Sell12,651$16.79$212,410.29211,000View SEC Filing Icon  
9/3/2024Sell11,609$14.60$169,491.40181,469View SEC Filing Icon  
6/25/2024Sell11,546$22.21$256,436.66177,449View SEC Filing Icon  
6/6/2024Sell98,635$21.42$2,112,761.70146,839View SEC Filing Icon  
3/20/2024Sell9,912$15.82$156,807.84168,627View SEC Filing Icon  
2/12/2024Sell31,363$10.03$314,570.89156,721View SEC Filing Icon  
2/9/2024Sell8,509$10.03$85,345.27161,699View SEC Filing Icon  
12/20/2023Sell6,784$8.58$58,206.72170,208View SEC Filing Icon  
11/21/2023Sell6,698$7.62$51,038.76144,284View SEC Filing Icon  
9/20/2023Sell6,794$6.28$42,666.32150,982View SEC Filing Icon  
8/21/2023Sell6,698$6.92$46,350.16125,016View SEC Filing Icon  
3/17/2023Sell15,720$9.82$154,370.4099,013View SEC Filing Icon  
See Full Table

Oluyemi Okupe Buying and Selling Activity at Hims & Hers Health

This chart shows Oluyemi Okupe's buying and selling at Hims & Hers Health by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Hims & Hers Health Company Overview

Hims & Hers Health logo
Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.
Read More

Today's Range

Now: $26.20
Low: $25.31
High: $27.13

50 Day Range

MA: $25.78
Low: $18.85
High: $34.23

2 Week Range

Now: $26.20
Low: $8.09
High: $35.02

Volume

17,248,361 shs

Average Volume

10,078,416 shs

Market Capitalization

$5.72 billion

P/E Ratio

59.55

Dividend Yield

N/A

Beta

1.25